Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy

INTRODUCTION: The Gleason score is a strong prognostic factor for treatment failure in pathologically organ-confined prostate cancer (pT2) treated by radical prostatectomy (RP). However, within each Gleason score, there is clinical heterogeneity with respect to treatment outcome, even in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal, Lopez, Marco Antonio, Minzer, Simona, Orrego, Shenda, Guzman, Eghon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605630/
https://www.ncbi.nlm.nih.gov/pubmed/31281431
http://dx.doi.org/10.3332/ecancer.2019.934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605630/
https://www.ncbi.nlm.nih.gov/pubmed/31281431
http://dx.doi.org/10.3332/ecancer.2019.934

Ejemplares similares